↓ Skip to main content

Cochrane Database of Systematic Reviews

Olanzapine in long-term treatment for bipolar disorder

Overview of attention for article published in Cochrane database of systematic reviews, January 2009
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter
wikipedia
12 Wikipedia pages

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
210 Mendeley
Title
Olanzapine in long-term treatment for bipolar disorder
Published in
Cochrane database of systematic reviews, January 2009
DOI 10.1002/14651858.cd004367.pub2
Pubmed ID
Authors

Andrea Cipriani, Jennifer M Rendell, John Geddes

Abstract

Many patients with bipolar disorder require long-term treatment to prevent recurrence. Antipsychotic drugs are often used to treat acute manic episodes. It is important to clarify whether olanzapine could have a role in long-term prevention of manic and depressive relapses.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 210 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Australia 1 <1%
Brazil 1 <1%
India 1 <1%
Canada 1 <1%
Spain 1 <1%
Unknown 204 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 15%
Student > Bachelor 28 13%
Student > Master 23 11%
Student > Ph. D. Student 16 8%
Student > Doctoral Student 16 8%
Other 42 20%
Unknown 54 26%
Readers by discipline Count As %
Medicine and Dentistry 73 35%
Psychology 31 15%
Pharmacology, Toxicology and Pharmaceutical Science 12 6%
Nursing and Health Professions 10 5%
Computer Science 5 2%
Other 22 10%
Unknown 57 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2021.
All research outputs
#5,956,641
of 21,346,872 outputs
Outputs from Cochrane database of systematic reviews
#7,953
of 12,076 outputs
Outputs of similar age
#39,557
of 144,162 outputs
Outputs of similar age from Cochrane database of systematic reviews
#57
of 102 outputs
Altmetric has tracked 21,346,872 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 12,076 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.0. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,162 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.